Literature DB >> 12761159

Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement.

Philippe Avenaud1, Brigitte Le Bail, Kathryn Mayo, Armelle Marais, Rabia Fawaz, Paulette Bioulac-Sage, Francis Megraud.   

Abstract

It has been reported that Helicobacter hepaticus infection of mice leads to chronic hepatitis and hepatocarcinoma. Our aim was to monitor a cohort of 80 conventional A/J mice in which half of the mice were infected by H. hepaticus in order to study the evolution of the infection and the pathological changes in comparison to uninfected mice. H. hepaticus was detected by culture only in some colon and cecum specimens after 17 months of age, while PCR detected H. hepaticus in the intestines of all inoculated mice after only 5 months of infection. The percentage of mice in which H. hepaticus was detected in the gallbladder, bile ducts, and liver by PCR, as well as the number of bacteria present in the liver, tended to increase with increasing age and longer infection time. Anti-H. hepaticus immunoglobulin G antibodies were positive by enzyme-linked immunosorbent assay only in inoculated mice. Pathological findings were also more frequent as the mice grew older: fibrosis was present (especially in the peripheral part of the liver), and significant portal inflammation including lymphoid nodules was present in almost all infected animals. Biliary lesions of neutrophilic acute cholangitis or lymphocytic cholangitis were noted. However, lesions were also observed in uninfected animals, although at a significantly lower level, and the only hepatocellular carcinoma occurred in an uninfected mouse. The evolution towards hepatocarcinoma is not always the endpoint and may depend on the bacterial strain and on the environmental conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761159      PMCID: PMC155737          DOI: 10.1128/IAI.71.6.3667-3672.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Age-related alterations in 32P-postlabeled DNA adducts in livers of mice infected with the tumorigenic bacterial pathogen, Helicobacter hepaticus.

Authors:  S Josyula; H A Schut; B A Diwan; M R Anver; L M Anderson
Journal:  Int J Oncol       Date:  2000-10       Impact factor: 5.650

2.  Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.

Authors:  M C Kullberg; A G Rothfuchs; D Jankovic; P Caspar; T A Wynn; P L Gorelick; A W Cheever; A Sher
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp.

Authors:  Chih-Ching Chien; Nancy S Taylor; Zhongming Ge; David B Schauer; Vincent B Young; James G Fox
Journal:  J Med Microbiol       Date:  2000-06       Impact factor: 2.472

4.  Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma.

Authors:  P Avenaud; A Marais; L Monteiro; B Le Bail; P Bioulac Sage; C Balabaud; F Mégraud
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

5.  Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica.

Authors:  A Occhialini; A Marais; M Urdaci; R Sierra; N Muñoz; A Covacci; F Mégraud
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Development of a PCR-restriction fragment length polymorphism assay using the nucleotide sequence of the Helicobacter hepaticus urease structural genes ureAB.

Authors:  Z Shen; D B Schauer; H L Mobley; J G Fox
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

7.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

9.  Local and systemic immune responses in murine Helicobacter felis active chronic gastritis.

Authors:  J G Fox; M Blanco; J C Murphy; N S Taylor; A Lee; Z Kabok; J Pappo
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis.

Authors:  Marika C Kullberg; Dragana Jankovic; Peter L Gorelick; Patricia Caspar; John J Letterio; Allen W Cheever; Alan Sher
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  8 in total

1.  Helicobacter hepaticus hydrogenase mutants are deficient in hydrogen-supported amino acid uptake and in causing liver lesions in A/J mice.

Authors:  Nalini S Mehta; Stephane Benoit; Jagannatha V Mysore; Renato S Sousa; Robert J Maier
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

3.  Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study.

Authors:  Gwen Murphy; Angelika Michel; Philip R Taylor; Demetrius Albanes; Stephanie J Weinstein; Jarmo Virtamo; Dominick Parisi; Kirk Snyder; Julia Butt; Katherine A McGlynn; Jill Koshiol; Michael Pawlita; Gabriel Y Lai; Christian C Abnet; Sanford M Dawsey; Neal D Freedman
Journal:  Hepatology       Date:  2014-07-30       Impact factor: 17.425

Review 4.  Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Peter Fickert
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

5.  Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models.

Authors:  Danmei Su; Yuanyang Nie; Airu Zhu; Zishuo Chen; Pengfei Wu; Li Zhang; Mei Luo; Qun Sun; Linbi Cai; Yuchen Lai; Zhixiong Xiao; Zhongping Duan; Sujun Zheng; Guihui Wu; Richard Hu; Hidekazu Tsukamoto; Aurelia Lugea; Zhenqui Liu; Stephen J Pandol; Yuan-Ping Han
Journal:  Front Physiol       Date:  2016-11-15       Impact factor: 4.566

6.  Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure.

Authors:  Bhalchandra A Diwan; Marek Sipowicz; Daniel Logsdon; Peter Gorelick; Miriam R Anver; Kazimierz S Kasprzak; Lucy M Anderson
Journal:  Environ Health Perspect       Date:  2008-06-13       Impact factor: 9.031

7.  Helicobacter species are associated with possible increase in risk of biliary lithiasis and benign biliary diseases.

Authors:  Manoj Pandey
Journal:  World J Surg Oncol       Date:  2007-08-20       Impact factor: 2.754

8.  Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes.

Authors:  Moritz Kleine; Tim Worbs; Harald Schrem; Florian W R Vondran; Alexander Kaltenborn; Jürgen Klempnauer; Reinhold Förster; Christine Josenhans; Sebastian Suerbaum; Hüseyin Bektas
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.